MYR 0.14
(-3.57%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 38.31 Million | -88.48 Million | 36.72 Million | 36.51 Million | -10.88 Million |
Net Income | -8.29 Million | -3.29 Million | 61.95 Million | 10.92 Million | -1.54 Million |
Depreciation & Amortization | 7.65 Million | 7.92 Million | 8.64 Million | 7.86 Million | 8.53 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 30.5 Million | -93.29 Million | -27.42 Million | 11.58 Million | -25.45 Million |
Other non-cash items | 11.84 Million | 8.41 Million | 5.73 Million | 8.94 Million | 7.57 Million |
Investing Cash Flow | -9.78 Million | -21.66 Million | 5 Million | -2.82 Million | -3.5 Million |
Investments in PPE | -20.17 Million | -9.08 Million | -4.64 Million | -3.87 Million | -1.8 Million |
Acquisitions | - | - | 1.19 Million | - | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | 9.5 Million | -15.6 Million | 7.38 Million | 111.96 Thousand | 549.94 Thousand |
Financing Cash Flow | -44.75 Million | 86.06 Million | 5.41 Million | -26.26 Million | 14.85 Million |
Debt repayment | -17.45 Million | -28.1 Million | -18.43 Million | -7.87 Million | -7.23 Million |
Dividends payments | -13.32 Million | -400 Thousand | -3.5 Million | -2.2 Million | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | 71.53 Million | - | - | - |
Other Financing Activities | -3.79 Million | 88.33 Million | -3.39 Million | -16.03 Million | 22.08 Million |
Accounts receivables | -24.41 Million | -2.18 Million | 18.36 Million | -43.66 Million | -787.92 Thousand |
Accounts payables | - | - | - | - | - |
Inventory | 74.12 Million | -120.22 Million | -32.46 Million | 53.9 Million | -22.19 Million |
Other working capital | 4.01 Million | - | -591 Thousand | 753.97 Thousand | -2.47 Million |
Cash at beginning of period | 28.36 Million | 52.44 Million | 5.29 Million | -2.12 Million | -2.58 Million |
Cash at end of period | 12.14 Million | 28.36 Million | 52.44 Million | 5.29 Million | -2.12 Million |
Capital Expenditure | -20.17 Million | -9.08 Million | -4.64 Million | -3.87 Million | -1.8 Million |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | -16.22 Million | -24.07 Million | 47.14 Million | 7.42 Million | 458.3 Thousand |
Free Cash Flow | 18.13 Million | -97.56 Million | 32.07 Million | 32.64 Million | -12.69 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 346 Thousand | 1.62 Million | -8.29 Million | 561 Thousand | -11.12 Million | 82 Thousand |
Depreciation & Amortization | 1.88 Million | 1.77 Million | 7.65 Million | 1.77 Million | 1.9 Million | 1.98 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 34.24 Million | -36.8 Million | 30.5 Million | -24.16 Million | 18.91 Million | 27.89 Million |
Other non-cash items | 8.45 Million | 12.15 Million | 11.84 Million | 2.92 Million | 13.5 Million | 1.49 Million |
Investing Cash Flow | -13.33 Million | -5.11 Million | -9.78 Million | 6.75 Million | -4.79 Million | -7.39 Million |
Investments in PPE | -8.92 Million | -5.34 Million | -20.17 Million | -7.58 Million | -3.97 Million | -4.47 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -972 Thousand | 184 Thousand | 9.5 Million | 14.14 Million | -1.03 Million | -3.3 Million |
Financing Cash Flow | -47.56 Million | 35.85 Million | -44.75 Million | 18.7 Million | -2.16 Million | -48.66 Million |
Debt repayment | -47.69 Million | -38.44 Million | -17.45 Million | -22.71 Million | -1 Million | -45.24 Million |
Dividends payments | - | - | -13.32 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -12.37 Million | -2.86 Million | -3.79 Million | 5.15 Million | -2.82 Million | -7.16 Million |
Accounts receivables | 24.12 Million | -31.71 Million | -24.41 Million | -31.92 Million | -6.3 Million | 15.28 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | 4.55 Million | -14.65 Million | 74.12 Million | 2.92 Million | 14.72 Million | 10.62 Million |
Other working capital | 5.56 Million | - | 4.01 Million | 4.01 Million | - | - |
Cash at beginning of period | 12.13 Million | 12.14 Million | 28.36 Million | 3.22 Million | -2.54 Million | 23.59 Million |
Cash at end of period | -9.41 Million | 12.13 Million | 12.14 Million | 12.14 Million | 3.22 Million | -2.54 Million |
Capital Expenditure | -8.92 Million | -5.34 Million | -20.17 Million | -7.58 Million | -3.97 Million | -4.47 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -21.54 Million | -12 Thousand | -16.22 Million | 8.91 Million | 5.77 Million | -26.14 Million |
Free Cash Flow | 30.42 Million | -36.09 Million | 18.13 Million | -24.13 Million | 8.75 Million | 25.44 Million |
AXIL
688128
4422
688565
BORORENEW
OXB